Azacitidine and Lenalidomide as an Alternative Treatment for Refractory Acute Myeloid Leukemia: A Case Report

Sao Paulo Medical Journal - Brazil
doi 10.1590/1516-3180.2012.6790006
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

PLoS ONE
Multidisciplinary
2010English

An Interesting Case of Acute Myeloid Leukemia

Journal of Medical Science And clinical Research
2017English

Salvage Treatment for Refractory or Relapsed Acute Myeloid Leukemia: A 10-Year Single-Center Experience

Clinics
Medicine
2020English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology
Cancer ResearchOncology
2019English

Small-Bowel Myeloid Sarcoma Presenting as a Relapse Case of Acute Myeloid Leukemia

Annals of Pathology and Laboratory Medicine
2018English

Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study

Oncotarget
Oncology
2016English

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy